TABLE 1.

S. porcinus strains from human sources included in this study

Strain	Yr of isolation/location	Clinical source	Age (yr)	Sex	Serogroup	Tetr genea
1499-84	1984/New York	Blood	NBb	Female	NG1 (C1)	tet(M)
628-86	1986/Oregon	Wound	20	Male	P	tet(O)
1217-87	1987/Louisiana	Placenta	27	Female	NG1 (C1)	tet(M)
1451-92	1992/New York	Placenta	NRc	Female	NG1 (C1)	tet(M)
638-93	1993/Canada	Cervix	26	Female	NG1 (C1)	S
2144-93	1993/Maryland	Cervix	NR	Female	P	S
219-94	1994/Georgia	Vagina	16	Female	NG1 (C1)	tet(M)
369-94	1994/South Carolina	Placenta	20	Female	NG1 (C1)	tet(M)
834-94	1994/Canada	Wound	47	Female	P	tet(M)
1013-94	1994/Georgia	Urine	34	Female	NG1 (C1)	tet(M)
1014-94	1994/Maryland	Genital tissue	NR	Female	NG1 (C1)	tet(M)
345-95	1995/Florida	Placenta	22	Female	NG1 (C1)	tet(M)
1256-95	1995/Florida	Wound	41	Male	NG1 (C1)	tet(M)
1533-95	1995/Florida	Cervix	22	Female	NG1 (C1)	tet(O)
2885-95	1995/New Jersey	Blood	39	Female	NG1 (C1)	tet(M)
3676-95	1995/New York	Wound	NR	NR	NG1 (C1)	S
4188-95	1995/Georgia	NR	NR	NR	NG1 (C1)	S
4189-95	1995/Georgia	NR	NR	NR	NG1 (C1)	S
663-96	1996/New Jersey	NR	30	Female	NG1 (C1)	tet(M)
4524-96	1996/Georgia	Placenta	NR	Female	NG1 (C1)	tet(M)
3123-97	1997/Philadelphia	Cervix	25	Female	NG1 (C1)	tet(M)
3176-97	1997/Georgia	Umbilicus	NR	NR	NG1 (C1)	tet(M)/tet(O)
790-98	1998/Alberta	Placenta	33	Female	NG1 (C1)	tet(M)/tet(O)
3657-98	1998/London	Vagina	NR	Female	NG1 (C1)	tet(M)/tet(O)
3658-98	1998/London	Placenta	NR	Female	NG1 (C1)	tet(M)/tet(O)

^aThat is, the tetracycline resistance gene. S, isolate susceptible to tetracycline.

^bNB, newborn.

^cNR, not reported.